Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Nisheeth Desai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India. Hauptthemen laut MEDLINE: Oxadiazoles, Anti-Infective Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Antimicrobial resistance which is increasing at an alarming rate is a severe public health issue worldwide. Hence, the development of novel antibiotics is an urgent need as microbes have developed resistance against available antibiotics. In search of novel antimicrobial agents, a convenient route for the preparation of substituted 3‐(1‐phenyl‐3‐( p ‐tolyl)‐1 H ‐pyrazol‐4‐yl)‐1‐(2‐phenyl‐5‐(pyridin‐3‐yl)‐1,3,4‐oxadiazol‐3(2 H )‐yl)prop‐2‐en‐1‐ones ( 6a – 6o ) has been adopted by using pyridine‐3‐carbohydrazide and various aromatic aldehydes. The newly synthesized compounds were characterized by using various spectral techniques, for example, IR, 1 H NMR, 13 C NMR, and mass spectroscopy. Synthesized hybrids were studied for in vitro antimicrobial potency against various bacterial and fungal strains. Antibacterial results revealed that compounds 6e, 6h, 6i, 6l , and 6m were found to be most active against bacterial strains as they showed minimum inhibitory concentration (MIC) value of 62.5 μg/mL while compounds 6d, 6e , and 6h showed MIC value of 200 μg/mL against Candida albicans . The quantum parameters that relate to the bioavailability of the compounds were computed, followed by docking with different bacterial and fungal targets like sortase A, dihydrofolate reductase, thymidylate kinase, gyrase B, sterol 14‐alpha demethylase. The experimental and computational results are in good agreement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India.
- Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Odisha, India.
- School of Science, Indrashil University, Kadi, Gujarat, India.
Zitieren
APA
Desai, N., Jadeja, D., Monapara, J., Panda, S. K., Rana, M. K., & Dave, B. (2023). Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23377
Vancouver
Desai N, Jadeja D, Monapara J, Panda SK, Rana MK, Dave B. Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23377
BibTeX
@article{Desai2023,
author = {Desai, Nisheeth and Jadeja, Dharmpalsinh and Monapara, Jahnvi and Panda, Saroj Kumar and Rana, Malay Kumar and Dave, Bharti},
title = {Design, synthesis, antimicrobial activity, DFT, and molecular docking studies of pyridine‐pyrazole‐based dihydro‐1,3,4‐oxadiazoles against various bacterial and fungal targets},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23377}
}
EUVIMED